Search Results 111-120 of 9888 for Lisdexamfetamine

  1. A Study Designed To Evaluate The Safety And Efficacy Of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) In Participants With T(11;14)-Positive Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    A Study Designed To Evaluate The Safety And Efficacy Of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) In ...

  2. Doctors and departments

    Researchers at Mayo Clinic are involved in the study of dementia and in improving diagnosis and treatment of the disorder. You might have access to a ...

  3. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors - Mayo Clinic

    About this study. Tinostamustine (EDO-S101) is a new chemical entity, an AK-DAC (a first-in-class alkylating deacetylase inhibiting molecule) that, ...

  4. A Phase 1-2 Dose-Escalation And Cohort-Expansion Study Of Oral EFT508 In Subjects With Hematological Malignancies - Mayo Clinic

    This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, ...

  5. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...

  6. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...

  7. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia. A study to ...

  8. Study Of The EZH2 Inhibitor Tazemetostat In Malignant Mesothelioma - Mayo Clinic

    In Part 1, 12 subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status will be treated and undergo pharmacokinetics (PK) blood ...

  9. Neurology - Clinical trials - Mayo Clinic

    This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data, brain imaging ...

  10. PRGN-3006 Adoptive Cellular Therapy For CD33-Positive Relapsed Or Refractory AML, MRD Positive AML Or Higher Risk MDS - Mayo Clinic

    The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...